We examined the antibacterial activities against Staphylococcus aureus of three diterpenes, namely, geranylgeraniol, teprenone, and phytol, by using a broth dilution with shaking method to identify the effects of diterpenes with long aliphatic carbon chains. We also performed time-kill assays and measured the leakage of K(+) ions from bacterial cells in response to these diterpenes. The diterpenes used inhibited the growth of S. aureus at concentrations of 0.15 microg/ml, as determined by damage to the cell membranes, and had clear bactericidal activity. However, the inhibitory effects of the diterpenes decreased when the concentration of each was raised above a certain level. The diterpenes tested in this study appeared to have both growth-inhibitory and growth-accelerating effects, and the net effect of each depended on its concentration.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087616 | PMC |
| http://dx.doi.org/10.1128/AAC.49.5.1770-1774.2005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Geranylgeraniol: Bio-based platform for teprenone, menaquinone-4, and α-tocotrienol synthesis.
Bioresour Technol
November 2024
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, Wuhan, China; Department of Urology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China; Wuhan Hesheng Technology Co., Ltd, Wuhan, China; TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. Electronic address:
Article Synopsis
- * This study introduces a new strategy that uses a chemosynthesis-like method to emphasize the value of biobased intermediates, specifically focusing on geranylgeraniol (GGOH) production.
- * Through advanced metabolic engineering and a novel yeast strain, researchers achieved significant GGOH production, which led to the semi-synthesis of several pharmaceuticals, suggesting new possibilities for industrial production improvements and innovations.
Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibition.
Mol Cancer Ther
July 2014
Authors' Affiliations: Departments of Molecular and Comparative Pathobiology, and
Doxorubicin is a widely used chemotherapy for solid tumors and hematologic malignancies, but its use is limited due to cardiotoxicity. Geranylgeranylacetone (GGA), an antiulcer agent used in Japan for 30 years, has no significant adverse effects, and unexpectedly reduces ovarian cancer progression in mice. Because GGA reduces oxidative stress in brain and heart, we hypothesized that GGA would prevent oxidative stress of doxorubicin cardiac toxicity and improve doxorubicin's chemotherapeutic effects.
View Article and Find Full Text PDFAnti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
Liver Int
July 2011
Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Background: Previously we reported that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, statins, inhibited hepatitis C virus (HCV) RNA replication. Furthermore, recent reports revealed that the statins are associated with a reduced risk of hepatocellular carcinoma and lower portal pressure in patients with cirrhosis. The statins exhibited anti-HCV activity by inhibiting geranylgeranylation of host proteins essential for HCV RNA replication.
View Article and Find Full Text PDFIsoprenoid geranylgeranylacetone inhibits human colon cancer cells through induction of apoptosis and cell cycle arrest.
Anticancer Drugs
October 2010
Department of Transfusion Medicine, University of Tokyo, Japan.
Geranylgeranylacetone (GGA), an isoprenoid compound, is a widely used antiulcer drug developed in Japan. GGA is structurally similar to plaunotol and geranylgeraniol, another isoprenoid reported to exert strong anticancer effects. In an earlier study, GGA was shown to inhibit ovarian cancer invasion by attenuating not only Rho activation, but also Ras-MAPK activation.
View Article and Find Full Text PDFBiphasic effects of geranylgeraniol, teprenone, and phytol on the growth of Staphylococcus aureus.
Antimicrob Agents Chemother
May 2005
Department of Microbiology, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
We examined the antibacterial activities against Staphylococcus aureus of three diterpenes, namely, geranylgeraniol, teprenone, and phytol, by using a broth dilution with shaking method to identify the effects of diterpenes with long aliphatic carbon chains. We also performed time-kill assays and measured the leakage of K(+) ions from bacterial cells in response to these diterpenes. The diterpenes used inhibited the growth of S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!